Valeant's (VRX) hostile takeover bid for Cephalon (CEPH) is certainly living up to the "hostile" part: A slideshow it made for investors basically says, "You suck, Cephalon. Hand over your shares by ...

Cephalon recently persuaded a federal judge in Delaware to dismiss a derivative suit filed by shareholder Jerald King, but her ruling describes a fascinating timeline of wrongdoing at the company. At ...

Drug developer Cephalon (NASDAQ:CEPH) had a busy year in 2006. The diversified mid-cap pharmaceutical company has had multiple successes and failures with its drugs on the regulatory and financial ...

FRAZER, Pa., Jan. 28 /PRNewswire-FirstCall/ -- Cephalon, Inc., (NASDAQ: CEPH) today announced the promotion of three executives, Kevin Buchi, Wilco Groenhuysen and ...

Critics of Scott Gottlieb, MD — President Donald Trump’s pick to head the Food and Drug Administration — question his involvement in helping the drugmaker Cephalon acquire more fentanyl during a 2006 ...

FRAZER, Pa., Aug. 10 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) announced today that it has completed its previously announced acquisition of all of the ...

Cephalon named CFO Kevin Buchi chief operating officer with responsibility for worldwide pharmaceutical operations, worldwide technical operations, investor relations and business development. Buchi ...

The FDA’s Division of Drug Marketing, Advertising and Communications (DDMAC) issued an untitled letter to Cephalon, Inc. on June 21 after reviewing the company’s HCP website for the injectible drug ...

NEW YORK, March 29 (Reuters) - Canadian drugmaker Valeant Pharmaceuticals International said it made an unsolicited $5.7 billion bid to buy Cephalon Inc and plans to make its case directly to Cephalon ...

Powerful cancer pain drugs were given to patients with other conditions who cannot tolerate them. A program to curb the practice was run by companies that sell the drugs. By Emily Baumgaertner The ...

Cephalon, Inc., (Nasdaq: CEPH) today announced Frank Baldino, Jr., Ph.D., the company's Chairman and Chief Executive Officer, will take a temporary medical leave of ...